Concepedia

Noriaki Iwase

NI

Statistics

Publications

5

Citations

493

H-Index

5

Active since

1998

Affiliations

Harvard University(Current)

Broad Institute

Massachusetts General Hospital

Noriaki Iwase is an author at Harvard University specializing in tuberculosis drug development, enzyme inhibition, and medicinal chemistry.

Publications per year

1998–2016

5

Publications

5

Identification of Novel Inhibitors of <i>M. tuberculosis</i> Growth Using Whole Cell Based High-Throughput Screening

Sarah A. Stanley, Sarah Schmidt Grant, Tomohiko Kawate et al. · ACS Chemical Biology · 2012 · 253 citations

, , +13

Diarylcoumarins inhibit mycolic acid biosynthesis and kill <i>Mycobacterium tuberculosis</i> by targeting FadD32

Sarah A. Stanley, Tomohiko Kawate, Noriaki Iwase et al. · Proceedings of the National Academy of Sciences · 2013 · 96 citations · Full text

, , +17

Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors

Sarah Schmidt Grant, Samantha Wellington, Tomohiko Kawate et al. · Cell chemical biology · 2016 · 62 citations · Full text

, , +9

Synthesis and structure–activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32

Tomohiko Kawate, Noriaki Iwase, Motohisa Shimizu et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 61 citations

, , +7

Substrate Specificity of 2-Deoxy-<i>scyllo</i>-inosose Synthase, the Starter Enzyme for 2-Deoxystreptamine Biosynthesis, toward Deoxyglucose-6-phosphates and Proposed Mechanism

Noriaki Iwase, Fumitaka Kudo, Noriaki Yamauchi · Bioscience Biotechnology and Biochemistry · 1998 · 21 citations · Full text

, , +10

1–5 of 5